Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) Announces Second Subject Enrolled In The Pilot Study

http://www.usmarketsdaily.com/invivo-therapeutics-holdings-corp-otcmktsnviv-announces-second-subject-enrolled-in-the-pilot-study-8580

Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) said that a second subject has been registered in the pilot research of its Neuro-Spinal Scaffold which is used for the treatment of traumatic spinal cord injury. The study will be conducted at the Carolinas Medical Center in Charlotte, NC. It will evaluate the…